Phase
Condition
Obesity
Ulcerative Colitis
Inflammatory Bowel Disease
Treatment
Lifestyle Intervention
Apollo Endoscopic Suture System
Clinical Study ID
Ages 22-69 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
BMI 30-50 kg/m2 for at least 6 months prior to ESG
Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)
Willing to adhere to the diet and behavior modifications required for ESG
Able to follow the visit schedule
Able to provide informed consent
If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin (HCG) at screening/baseline
Exclusion
Exclusion Criteria:
Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG
Current or recent (last six months) gastric or duodenal ulceration
Esophageal or gastric varices
Significant motility disorder of the esophagus or stomach
Large hiatal hernia measuring >5 cm or ≤ 5 cm and associated with severegastroesophageal reflux
Severe coagulopathy, hepatic insufficiency, or cirrhosis
Gastric mass
Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease
Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits
Unwilling to participate in an established diet and behavior modification program,with routine follow-up
Ongoing corticosteroid use at a dose of >5 mg daily
Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision
Alcohol or drug addiction
Females who are pregnant, nursing, or planning pregnancy within the next year
Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations
Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study
Study Design
Connect with a study center
Mayo Clinic Minnesota
Rochester, Minnesota 55905
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.